| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $2.7M | -82.1% |
| SG&A Expense | $9.0M | -28.4% |
| Operating Income | -$11.7M | +57.6% |
| Interest Expense | $0 | -100.0% |
| Net Income | -$11.6M | +56.9% |
| EPS (Basic) | -$0.55 | +64.7% |
| EPS (Diluted) | -$0.55 | +64.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125K | -98.4% |
| Current Assets | $390K | -95.2% |
| Total Assets | $392K | -95.2% |
| Current Liabilities | $7.5M | +78.8% |
| Stockholders' Equity | -$6.6M | -263.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.1M | +28.9% |
| Capital Expenditures | $2K | -22.4% |
| Financing Cash Flow | $242K | -98.6% |
| Free Cash Flow | -$8.1M | +28.9% |